| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
176,112 | 213,646 | 228,614 | 306,911 | 369,193 |
| Cost of Revenue
|
-104,004 | -92,778 | -147,232 | -141,370 | -126,709 |
|
Gross Profit
|
72,108 | 120,868 | 81,382 | 165,541 | 242,484 |
| Selling, General and Administrative Expenses
|
-77,696 | -115,003 | -152,310 | -199,938 | -304,416 |
|
Research and Development Expenses
|
-19,014 | -19,806 | -20,869 | -22,219 | -30,411 |
|
Operating Income/Expenses
|
-96,710 | -134,809 | -173,179 | -222,157 | -334,827 |
|
Total Operating Profit/Loss
|
-24,602 | -13,941 | -91,797 | -56,616 | -92,343 |
| Total Net Finance Income/Expense
|
10,414 | 10,846 | 13,396 | 11,855 | 2,804 |
| Irregular Income/Expenses
|
-7,427 | -36,229 | 0 | -10,972 | -13,526 |
|
Other Income/Expense, Non-Operating
|
4,487 | 3,276 | 1,201 | 2,063 | -740 |
|
Non-Operating Income/Expenses, Total
|
7,474 | -22,107 | 14,597 | 2,946 | -11,462 |
|
Pretax Income
|
-17,128 | -36,048 | -77,200 | -53,670 | -103,805 |
|
Provision for Income Tax
|
-2,013 | -2,750 | -4,983 | -5,442 | -1,998 |
|
Net Income from Continuing Operations
|
-19,141 | -38,798 | -82,183 | -59,112 | -105,803 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-19,141 | -38,798 | -82,183 | -59,112 | -105,803 |
|
Net Income after Non-Controlling/Minority Interests
|
-19,141 | -38,798 | -82,183 | -59,112 | -105,803 |
|
Net Income Available to Common Stockholders
|
-19,141 | -38,798 | -82,183 | -59,112 | -105,803 |
|
Diluted Net Income Available to Common Stockholders
|
-19,141 | -38,798 | -82,183 | -59,112 | -105,803 |
| Basic EPS
|
-0.80 | -1.80 | -4.00 | -3.00 | -5.20 |
| Diluted EPS
|
-0.80 | -1.80 | -4.00 | -3.00 | -5.20 |
|
Basic Weighted Average Shares Outstanding
|
20,958.11 | 20,749.20 | 20,546.85 | 20,382.75 | 20,057.75 |
|
Diluted Weighted Average Shares Outstanding
|
20,958.11 | 20,749.20 | 20,546.85 | 20,382.75 | 20,057.75 |
|
Reported Normalized Basic EPS
|
0.20 | 0.80 | -1.40 | 0.60 | -2.40 |
|
Reported Normalized Diluted EPS
|
0.20 | 0.80 | -1.40 | 0.60 | -2.40 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-27,542 | -46,894 | -90,596 | -65,525 | -106,609 |
|
EBITDA
|
-24,926 | -43,866 | -87,583 | -62,560 | -103,513 |
|
Normalized EBITDA
|
-10,076 | 6,300 | -69,878 | -35,942 | -63,774 |
|
Normalized Income
|
5,018 | 16,189 | -28,004 | 14,038 | -47,394 |
|
Total Unusual Items
|
14,850 | 50,166 | 17,705 | 26,618 | 39,739 |
12/31/2022 - 4/1/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade